Isotype switching: Mouse IgG3 constant region drives increased affinity for polysaccharide antigens

References

• Kanswal S, Katsenelson N, Allman W, Uslu K, Blake MS, Akkoyunlu M. Suppressive effect of bacterial polysaccharides on BAFF system is responsible for their poor immunogenicity. J Immunol 2011; 186:2430-43; PMID:21248261; http://dx.doi.org/10.4049/jimmunol.1002976
   PubMed Web of Science ®Google Scholar
• Melin M, Jarva H, Siira L, Meri S, Kayhty H, Vakevainen M. Streptococcus pneumoniae capsular serotype 19F is more resistant to C3 deposition and less sensitive to opsonophagocytosis than serotype 6B. Infect Immun 2009; 77:676-84; PMID:19047408; http://dx.doi.org/10.1128/IAI.01186-08
   PubMed Web of Science ®Google Scholar
• Shaw BM, Daubenspeck JM, Simmons WL, Dybvig K. EPS-I polysaccharide protects Mycoplasma pulmonis from phagocytosis. FEMS Microbiol Lett 2013; 338:155-60; PMID:23190331; http://dx.doi.org/10.1111/1574-6968.12048
   PubMed Web of Science ®Google Scholar
• Fanning S, Hall LJ, Cronin M, Zomer A, MacSharry J, Goulding D, Motherway MO, Shanahan F, Nally K, Dougan G, et al. Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection. Proc Natl Acad Sci U S A 2012; 109:2108-13; PMID:22308390; http://dx.doi.org/10.1073/pnas.1115621109
   PubMed Web of Science ®Google Scholar
• Mishra M, Byrd MS, Sergeant S, Azad AK, Parsek MR, McPhail L, Schlesinger LS, Wozniak DJ. Pseudomonas aeruginosa Psl polysaccharide reduces neutrophil phagocytosis and the oxidative response by limiting complement-mediated opsonization. Cell Microbiol 2012; 14:95-106; PMID:21951860; http://dx.doi.org/10.1111/j.1462-5822.2011.01704.x
   PubMed Web of Science ®Google Scholar
• Reckseidler-Zenteno SL, DeVinney R, Woods DE. The capsular polysaccharide of Burkholderia pseudomallei contributes to survival in serum by reducing complement factor C3b deposition. Infect Immun 2005; 73:1106-15; PMID:15664954; http://dx.doi.org/10.1128/IAI.73.2.1106-1115.2005
   PubMed Web of Science ®Google Scholar
• Bentley SD, Aanensen DM, Mavroidi A, Saunders D, Rabbinowitsch E, Collins M, Donohoe K, Harris D, Murphy L, Quail MA, et al. Genetic analysis of the capsular biosynthetic locus from all 90 pneumococcal serotypes. PLoS Genet 2006; 2:e31; PMID:16532061; http://dx.doi.org/10.1371/journal.pgen.0020031
   PubMed Web of Science ®Google Scholar
• Whitfield C. Biosynthesis and assembly of capsular polysaccharides in Escherichia coli. Annu Rev Biochem 2006; 75:39-68; PMID:16756484; http://dx.doi.org/10.1146/annurev.biochem.75.103004.142545
   PubMed Web of Science ®Google Scholar
• Cadoz M. Potential and limitations of polysaccharide vaccines in infancy. Vaccine 1998; 16:1391-5; PMID:9711777; http://dx.doi.org/10.1016/S0264-410X(98)00097-8
   PubMed Web of Science ®Google Scholar
• Cutts FT, Zaman SM, Enwere G, Jaffar S, Levine OS, Okoko JB, Oluwalana C, Vaughan A, Obaro SK, Leach A, et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 2005; 365:1139-46; PMID:15794968; http://dx.doi.org/10.1016/S0140-6736(05)71876-6
   PubMed Web of Science ®Google Scholar
• Jackson LA, Gurtman A, van Cleeff M, Jansen KU, Jayawardene D, Devlin C, Scott DA, Emini EA, Gruber WC, Schmoele-Thoma B. Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults. Vaccine 2013; 31:3577-84; PMID:23688526; http://dx.doi.org/10.1016/j.vaccine.2013.04.085
   PubMed Web of Science ®Google Scholar
• Avci FY, Li X, Tsuji M, Kasper DL. A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design. Nat Med 2011; 17:1602-9; PMID:22101769; http://dx.doi.org/10.1038/nm.2535
   PubMed Web of Science ®Google Scholar
• Snape MD, Pollard AJ. Meningococcal polysaccharide-protein conjugate vaccines. Lancet Infect Dis 2005; 5:21-30; PMID:15620558; http://dx.doi.org/10.1016/S1473-3099(04)01251-4
   PubMed Web of Science ®Google Scholar
• Kurosaki T, Kometani K, Ise W. Memory B cells. Nat Rev Immunol 2015; 15:149-59; PMID:25677494; http://dx.doi.org/10.1038/nri3802
   PubMed Web of Science ®Google Scholar
• Gerdts V, Littel-van den Hurk S, Griebel PJ, Babiuk LA. Use of animal models in the development of human vaccines. Future Microbiol 2007; 2:667-75; PMID:18041907; http://dx.doi.org/10.2217/17460913.2.6.667
   PubMed Web of Science ®Google Scholar
• Davis MM. A prescription for human immunology. Immunity 2008; 29:835-8; PMID:19100694; http://dx.doi.org/10.1016/j.immuni.2008.12.003
   PubMed Web of Science ®Google Scholar
• Mestas J, Hughes CC. Of mice and not men: differences between mouse and human immunology. J Immunol 2004; 172:2731-8; PMID:14978070; http://dx.doi.org/10.4049/jimmunol.172.5.2731
   PubMed Web of Science ®Google Scholar
• Nesspor TC, Raju TS, Chin CN, Vafa O, Brezski RJ. Avidity confers FcgammaR binding and immune effector function to aglycosylated immunoglobulin G1. J Mol Recognit 2012; 25:147-54; PMID:22407978; http://dx.doi.org/10.1002/jmr.2155
   PubMed Web of Science ®Google Scholar
• Janda A, Eryilmaz E, Nakouzi A, Cowburn D, Casadevall A. Variable region identical immunoglobulins differing in isotype express different paratopes. J Biol Chem 2012; 287:35409-17; PMID:22930758; http://dx.doi.org/10.1074/jbc.M112.404483
   PubMed Web of Science ®Google Scholar
• Torres M, May R, Scharff MD, Casadevall A. Variable-region-identical antibodies differing in isotype demonstrate differences in fine specificity and idiotype. J Immunol 2005; 174:2132-42; PMID:15699144; http://dx.doi.org/10.4049/jimmunol.174.4.2132
   PubMed Web of Science ®Google Scholar
• Janda A, Casadevall A. Circular Dichroism reveals evidence of coupling between immunoglobulin constant and variable region secondary structure. Mol Immunol 2010; 47:1421-5; PMID:20299100; http://dx.doi.org/10.1016/j.molimm.2010.02.018
   PubMed Web of Science ®Google Scholar
• Russo TA, Beanan JM, Olson R, MacDonald U, Cox AD, St Michael F, Vinogradov EV, Spellberg B, Luke-Marshall NR, Campagnari AA. The K1 capsular polysaccharide from Acinetobacter baumannii is a potential therapeutic target via passive immunization. Infect Immun 2013; 81:915-22; PMID:23297385; http://dx.doi.org/10.1128/IAI.01184-12
   PubMed Web of Science ®Google Scholar
• Dillon MJ, Loban RA, Reed DE, Thorkildson P, Pflughoeft KJ, Pandit SG, Brett PJ, Burtnick MN, AuCoin DP. Contribution of Murine IgG Fc Regions to Antibody Binding to the Capsule of Burkholderia pseudomallei. Virulence 2016:1-11.
   PubMedGoogle Scholar
• Currie BJ, Kaestli M. Epidemiology: A global picture of melioidosis. Nature 2016; 529:290-1; PMID:26791716; http://dx.doi.org/10.1038/529290a
   PubMed Web of Science ®Google Scholar
• Limmathurotsakul D, Golding N, Dance DA, Messina JP, Pigott DM, Moyes CL, Rolim DB, Bertherat E, Day NP, Peacock SJ, et al. Predicted global distribution of and burden of melioidosis. Nat Microbiol 2016; 1:15008; PMID:26877885; http://dx.doi.org/10.1038/nmicrobiol.2015.8
   PubMed Web of Science ®Google Scholar
• Wiersinga WJ, Currie BJ, Peacock SJ. Melioidosis. N Engl J Med 2012; 367:1035-44; PMID:22970946; http://dx.doi.org/10.1056/NEJMra1204699
   PubMed Web of Science ®Google Scholar
• Cuccui J, Milne TS, Harmer N, George AJ, Harding SV, Dean RE, Scott AE, Sarkar-Tyson M, Wren BW, Titball RW, et al. Characterization of the Burkholderia pseudomallei K96243 capsular polysaccharide I coding region. Infect Immun 2012; 80:1209-21; PMID:22252864; http://dx.doi.org/10.1128/IAI.05805-11
   PubMed Web of Science ®Google Scholar
• Scott AE, Christ WJ, George AJ, Stokes MG, Lohman GJ, Guo Y, Jones M, Titball RW, Atkins TP, Campbell AS, et al. Protection against experimental melioidosis with a synthetic manno-heptopyranose hexasaccharide glycoconjugate. Bioconjug Chem 2016; http://dx.doi.org/10.1021/acs.bioconjchem.5b00525
   Web of Science ®Google Scholar
• Cooper LJ, Robertson D, Granzow R, Greenspan NS. Variable domain-identical antibodies exhibit IgG subclass-related differences in affinity and kinetic constants as determined by surface plasmon resonance. Mol Immunol 1994; 31:577-84; PMID:7515151; http://dx.doi.org/10.1016/0161-5890(94)90165-1
   PubMed Web of Science ®Google Scholar
• Hovenden M, Hubbard MA, Aucoin DP, Thorkildson P, Reed DE, Welch WH, Lyons CR, Lovchik JA, Kozel TR. IgG subclass and heavy chain domains contribute to binding and protection by mAbs to the poly gamma-D-glutamic acid capsular antigen of Bacillus anthracis. PLoS Pathog 2013; 9:e1003306; PMID:23637599; http://dx.doi.org/10.1371/journal.ppat.1003306
   PubMedGoogle Scholar
• Cooper LJ, Schimenti JC, Glass DD, Greenspan NS. H chain C domains influence the strength of binding of IgG for streptococcal group A carbohydrate. J Immunol 1991; 146:2659-63; PMID:1901882
   PubMed Web of Science ®Google Scholar
• Yoo EM, Wims LA, Chan LA, Morrison SL. Human IgG2 can form covalent dimers. J Immunol 2003; 170:3134-8; PMID:12626570; http://dx.doi.org/10.4049/jimmunol.170.6.3134
   PubMed Web of Science ®Google Scholar
• Vidarsson G, Dekkers G, Rispens T. IgG subclasses and allotypes: from structure to effector functions. Front Immunol 2014; 5:520; PMID:25368619; http://dx.doi.org/10.3389/fimmu.2014.00520
   PubMed Web of Science ®Google Scholar
• Yang J, Goetze AM, Flynn GC. Assessment of naturally occurring covalent and total dimer levels in human IgG1 and IgG2. Mol Immunol 2014; 58:108-15; PMID:24321397; http://dx.doi.org/10.1016/j.molimm.2013.11.011
   PubMed Web of Science ®Google Scholar